University of Sassari-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2013

  1. Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir

    Antiviral Therapy, Vol. 18, Núm. 5, pp. 709-715

2010

  1. Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes

    Journal of Viral Hepatitis, Vol. 17, Núm. 12, pp. 866-871

2009

  1. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: Influence of HIV infection

    Journal of Viral Hepatitis, Vol. 16, Núm. 11, pp. 790-795

  2. Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation

    Antiviral Therapy, Vol. 14, Núm. 2, pp. 187-193

2008

  1. Antiretroviral-associated portal hypertension: A new clinical condition? Prevalence, predictors and outcome

    Antiviral Therapy, Vol. 13, Núm. 1, pp. 103-107

2007

  1. Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases

    AIDS Research and Human Retroviruses, Vol. 23, Núm. 6, pp. 801-804

2006

  1. Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity

    HIV Clinical Trials, Vol. 7, Núm. 5, pp. 246-250